Table 1.
Patients characteristics
| Variable | N | % |
|---|---|---|
|
All |
149 |
100.0 |
|
T-stage |
|
|
|
1 |
105 |
70.5 |
|
> 1 |
44 |
29.5 |
|
N-stage |
|
|
|
0 |
91 |
61.1 |
|
> 1 |
58 |
38.9 |
|
Grade |
|
|
|
1 and 2 |
95 |
63.8 |
|
3 |
54 |
36.2 |
|
Histology |
|
|
|
IDC |
128 |
85.9 |
|
Other |
21 |
14.1 |
|
Hormone receptor status |
|
|
|
Negative |
19 |
12.8 |
|
Positive |
130 |
87.2 |
|
HER2 status |
|
|
|
Negative |
127 |
85.2 |
|
Amplified |
22 |
14.8 |
|
Ki 67 (cut-off 20%) |
|
|
|
Low |
92 |
61.7 |
|
High |
57 |
38.3 |
|
Lymphovascular invasion |
|
|
|
Present |
35 |
23.5 |
|
Absent |
114 |
76.5 |
|
Baseline CTC |
|
|
|
CTC Epithelial |
|
|
|
Negative |
133 |
89.3 |
|
Positive |
16 |
10.7 |
|
CTC EMT |
|
|
|
Negative |
126 |
84.6 |
|
Positive |
23 |
15.4 |
|
CTC Any |
|
|
|
Negative |
113 |
75.8 |
| Positive | 36 | 24.2 |